PubRank
Search
About
Martina Deckert
Author PubWeight™ 75.70
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.
J Exp Med
2004
2.58
2
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
Blood
2011
2.44
3
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
J Clin Oncol
2003
2.14
4
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.
Ann Neurol
2002
1.71
5
Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Am J Pathol
2007
1.51
6
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells.
Immunity
2012
1.50
7
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.
PLoS One
2009
1.48
8
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma.
Ann Neurol
2002
1.32
9
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene.
Mol Ther
2007
1.29
10
The induction and kinetics of antigen-specific CD8 T cells are defined by the stage specificity and compartmentalization of the antigen in murine toxoplasmosis.
J Immunol
2003
1.28
11
Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis.
J Immunol
2008
1.18
12
Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.
Acta Neuropathol
2011
1.17
13
Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess.
Am J Pathol
2007
1.16
14
Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
J Immunol
2003
1.11
15
Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Blood
2003
1.08
16
Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
Acta Neuropathol
2010
1.08
17
Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
J Immunol
2011
1.05
18
An essential role for tumor necrosis factor in the formation of experimental murine Staphylococcus aureus-induced brain abscess and clearance.
J Neuropathol Exp Neurol
2005
1.04
19
Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma.
Acta Neuropathol
2002
1.03
20
The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis.
J Neuropathol Exp Neurol
2004
1.02
21
Murine model of pregnancy-associated Listeria monocytogenes infection.
FEMS Immunol Med Microbiol
2003
1.01
22
Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
Br J Haematol
2011
1.00
23
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.
J Neurooncol
2008
0.97
24
Novel isolated cerebral ALlambda amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy.
J Neuropathol Exp Neurol
2009
0.96
25
Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells.
Infect Immun
2006
0.95
26
Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Hum Gene Ther
2004
0.95
27
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma.
Neuro Oncol
2010
0.95
28
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma.
J Nucl Med
2009
0.94
29
Primary lymphoma of the central nervous system: just DLBCL or not?
Blood
2008
0.94
30
Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
Eur J Haematol
2010
0.94
31
Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
J Neuropathol Exp Neurol
2008
0.93
32
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
Ann Neurol
2010
0.93
33
Hypertrophy of the lumbar ligamentum flavum is associated with inflammation-related TGF-β expression.
Acta Neurochir (Wien)
2010
0.91
34
Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors.
Glia
2002
0.91
35
Fatal cerebral lymphomatoid granulomatosis in an HIV-1-infected patient.
J Infect
2006
0.90
36
Chromosomal translocations fusing the BCL6 gene to different partner loci are recurrent in primary central nervous system lymphoma and may be associated with aberrant somatic hypermutation or defective class switch recombination.
J Neuropathol Exp Neurol
2006
0.90
37
Array-based DNA methylation profiling of primary lymphomas of the central nervous system.
BMC Cancer
2009
0.90
38
Protein kinase C-theta critically regulates the proliferation and survival of pathogen-specific T cells in murine listeriosis.
J Immunol
2008
0.90
39
Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites.
Am J Pathol
2007
0.90
40
Phenotype and regulation of persistent intracerebral T cells in murine Toxoplasma encephalitis.
J Immunol
2002
0.89
41
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
J Neuropathol Exp Neurol
2007
0.89
42
Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.
J Neuropathol Exp Neurol
2002
0.88
43
Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.
Acta Neuropathol
2013
0.87
44
Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes.
Acta Neuropathol
2013
0.87
45
Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.
J Neurooncol
2002
0.86
46
Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
Acta Neuropathol
2007
0.86
47
8-year-old child with a lesion in the left nucleus lentiformis.
Brain Pathol
2008
0.86
48
Toll-like receptors promote inflammation in idiopathic inflammatory myopathies.
J Neuropathol Exp Neurol
2012
0.85
49
Inflammatory myopathy with abundant macrophages and dermatomyositis: two stages of one disorder or two distinct entities?
Acta Neuropathol
2009
0.84
50
Regulation of the inflammatory response to Staphylococcus aureus-induced brain abscess by interleukin-10.
J Neuropathol Exp Neurol
2005
0.83
51
Effects of pregnancy-associated Listeria monocytogenes infection: necrotizing hepatitis due to impaired maternal immune response and significantly increased abortion rate.
Virchows Arch
2002
0.83
52
TNF is important for pathogen control and limits brain damage in murine cerebral listeriosis.
J Immunol
2006
0.83
53
Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis.
Am J Pathol
2012
0.82
54
Increased frequency of distinct TSC2 allelic variants in focal cortical dysplasias with balloon cells and mineralization.
Neuropathology
2009
0.82
55
CYLD enhances severe listeriosis by impairing IL-6/STAT3-dependent fibrin production.
PLoS Pathog
2013
0.82
56
CD4 T cells mediate axonal damage and spinal cord motor neuron apoptosis in murine p0106-125-induced experimental autoimmune neuritis.
Am J Pathol
2008
0.82
57
Genes regulating the B cell receptor pathway are recurrently mutated in primary central nervous system lymphoma.
Acta Neuropathol
2012
0.82
58
Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.
Am J Pathol
2005
0.81
59
Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.
Infect Immun
2010
0.81
60
P0(106-125) is a neuritogenic epitope of the peripheral myelin protein P0 and induces autoimmune neuritis in C57BL/6 mice.
J Neuropathol Exp Neurol
2005
0.80
61
Expression of the LGI1 gene product in astrocytic gliomas: downregulation with malignant progression.
Virchows Arch
2003
0.80
62
Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients.
Virchows Arch
2004
0.80
63
A20 expression in dendritic cells protects mice from LPS-induced mortality.
Eur J Immunol
2014
0.80
64
Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma.
Leuk Lymphoma
2010
0.79
65
Protective immunosurveillance of the central nervous system by Listeria-specific CD4 and CD8 T cells in systemic listeriosis in the absence of intracerebral Listeria.
J Immunol
2002
0.79
66
January 2002: 59-year-old woman with an intrasellar lesion.
Brain Pathol
2002
0.79
67
The inflammatory reaction pattern distinguishes primary dysferlinopathies from idiopathic inflammatory myopathies: an important role for the membrane attack complex.
Acta Neuropathol
2006
0.79
68
Dual role of B cells with accelerated onset but reduced disease activity in P0₁₀₆₋₁₂₅-induced experimental autoimmune neuritis of IgH ⁰(/)⁰ mice.
Acta Neuropathol
2010
0.77
69
VH gene analysis of primary CNS lymphomas.
J Neurol Sci
2004
0.77
70
Molecular mimicry between neurons and an intracerebral pathogen induces a CD8 T cell-mediated autoimmune disease.
J Immunol
2008
0.77
71
Listeria monocytogenes (delta-actA mutant) infection in tumor necrosis factor receptor p55-deficient neonatal mice.
Microb Pathog
2010
0.77
72
Listeriosis in pregnancy: case report and retrospective study.
J Matern Fetal Neonatal Med
2012
0.77
73
Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
J Neuropathol Exp Neurol
2009
0.76
74
Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partner.
Brain Pathol
2003
0.76
75
Immunoglobulin repertoire of primary lymphomas of the central nervous system.
J Neuropathol Exp Neurol
2014
0.76
76
Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma.
J Neuropathol Exp Neurol
2013
0.76
77
Intracranial ependymoma: long-term results in a series of 21 patients treated with stereotactic (125)iodine brachytherapy.
PLoS One
2012
0.76
78
Comment on "Critical roles of NK and CD8+ T cells in central nervous system listeriosis".
J Immunol
2009
0.75
79
Diagnostic impact of ornithine decarboxylase in meningiomas.
J Neurooncol
2004
0.75
80
Papillary tumors of the pineal region: a novel therapeutic option-stereotactic 125iodine brachytherapy.
J Neurooncol
2012
0.75
81
A 30-year-old patient with tuberous sclerosis.
Brain Pathol
2007
0.75
82
An unusual case of optic neuritis.
J Neurol Sci
2011
0.75
83
Whipple disease confined to the central nervous system presenting as a solitary frontal tumor. Case report.
J Neurosurg
2004
0.75
84
Corrigendum: Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channel.
Sci Rep
2016
0.75
85
Costimulatory molecule CD40 is essential for myelin protein 0 peptide 106-125-induced experimental autoimmune neuritis in mice.
J Neuropathol Exp Neurol
2014
0.75